Thermo Fisher/Life Tech Deal Overshadowed Soft Omics Tools, MDx M&A Market in H1 2013 | GenomeWeb

NEW YORK (GenomeWeb News) – The mergers and acquisitions market in the omics tools and molecular diagnostics space continues to be soft as the number of deals fell 11 percent year over year during the first half of 2013.

In the first half of the year, 24 deals were either completed or announced, down from 27 in the first half of 2012 and down from 28 from the second half of 2012. The figures include only those transactions in which the whole of a company was acquired. Not included were deals in which only divisions or assets exchanged hands.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.